Universal Ibogaine Inc.
IBOGF · OTC
7/31/2022 | 7/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $7,327 | $11,817 | $1,259 | $991 |
| - Cash | $726 | $142 | $73 | $205 |
| + Debt | $1,738 | $410 | $0 | $0 |
| Enterprise Value | $8,339 | $12,084 | $1,187 | $786 |
| Revenue | $1,071 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1,071 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$4,607 | -$3,763 | $1 | -$34 |
| % Margin | -430.3% | – | – | – |
| Net Income | -$10,496 | -$3,867 | -$118 | -$98 |
| % Margin | -980.2% | – | – | – |
| EPS Diluted | -0.057 | -0.031 | -0.01 | -0.01 |
| % Growth | -82.8% | -209% | 0% | – |
| Operating Cash Flow | -$4,333 | -$3,250 | -$122 | -$72 |
| Capital Expenditures | -$96 | $0 | -$2 | $0 |
| Free Cash Flow | -$4,429 | -$3,250 | -$124 | -$72 |